tiprankstipranks
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market

Compare Enliven Therapeutics (ELVN) vs. Competitors

331 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Enliven Therapeutics
$44.85
$2.62B
-8.42
160.91%
6 Buy
0 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$22.15
$2.29B
-3.16
-59.45%
6 Buy
13 Hold
5 Sell
Hold
Viridian Therapeutics
$15.19
$1.51B
-5.48
14.21%
13 Buy
1 Hold
0 Sell
Strong Buy
Intellia Therapeutics
$14.78
$1.68B
-2.54
97.07%
8 Buy
7 Hold
1 Sell
Moderate Buy
AbCellera Biologics
$3.76
$1.11B
-6.98
54.10%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ELVN
Enliven Therapeutics
44.85
27.80
163.05%
SRPT
Sarepta Therapeutics
22.15
-32.27
-59.30%
VRDN
Viridian Therapeutics
15.19
2.39
18.67%
CDTX
NTLA
Intellia Therapeutics
14.78
7.42
100.82%
ABCL
AbCellera Biologics
3.76
1.33
54.73%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts